FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lillynews2024-06-10T21:05:19+00:00June 10th, 2024|The New York Times|
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefitsnews2024-06-10T09:00:35+00:00June 10th, 2024|The New York Times|
FDA Panel Rejects Use of MDMA for Treatment of PTSDnews2024-06-04T23:06:17+00:00June 4th, 2024|The New York Times|
What Are the MDMA Risks of Therapy for PTSD?news2024-06-04T22:12:47+00:00June 4th, 2024|The New York Times|
Why PTSD Is So Hard to Diagnose and Treatnews2024-06-04T22:00:17+00:00June 4th, 2024|The New York Times|
FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flawsnews2024-05-31T19:08:30+00:00May 31st, 2024|The New York Times|
Ozempic May Help Treat Kidney Disease, Study Findsnews2024-05-24T10:35:06+00:00May 24th, 2024|The New York Times|
Abortion Pills May Become Controlled Substances in Louisiananews2024-05-23T01:57:38+00:00May 23rd, 2024|The New York Times|
Legal Weed Is Coming. It’s Time to Come Up With Some Rules.news2024-05-20T15:30:43+00:00May 20th, 2024|The New York Times|
